siRNA versus miRNA as therapeutics for gene silencing

JKW Lam, MYT Chow, Y Zhang, SWS Leung - Molecular Therapy-Nucleic …, 2015 - cell.com
Discovered a little over two decades ago, small interfering RNAs (siRNAs) and microRNAs
(miRNAs) are noncoding RNAs with important roles in gene regulation. They have recently …

Antiviral strategies targeting host factors and mechanisms obliging+ ssRNA viral pathogens

S Mahajan, S Choudhary, P Kumar, S Tomar - Bioorganic & Medicinal …, 2021 - Elsevier
The ongoing COVID-19 pandemic, periodic recurrence of viral infections, and the
emergence of challenging variants has created an urgent need of alternative therapeutic …

Computational and experimental advances in drug repositioning for accelerated therapeutic stratification

K Shameer, B Readhead… - Current topics in medicinal …, 2015 - ingentaconnect.com
Drug repositioning is an important component of therapeutic stratification in the precision
medicine paradigm. Molecular profiling and more sophisticated analysis of longitudinal …

Exploiting acquired vulnerability to develop novel treatments for cholangiocarcinoma

S Areewong, O Suppramote, S Prasopporn… - Cancer Cell …, 2024 - Springer
Cholangiocarcinoma (CCA) presents a formidable therapeutic challenge due to its extensive
heterogeneity and plasticity, which inevitably lead to acquired resistance to current …

Repurposing kinase inhibitors as antiviral agents to control influenza A virus replication

O Perwitasari, X Yan, J O'Donnell… - Assay and drug …, 2015 - liebertpub.com
Influenza A virus (IAV) infection causes seasonal epidemics of contagious respiratory illness
that causes substantial morbidity and some mortality. Regular vaccination is the principal …

Probenecid inhibits respiratory syncytial virus (RSV) replication

J Murray, HC Bergeron, LP Jones, ZB Reener… - Viruses, 2022 - mdpi.com
RNA viruses like SARS-CoV-2, influenza virus, and respiratory syncytial virus (RSV) are
dependent on host genes for replication. We investigated if probenecid, an FDA-approved …

Antiviral activity of probenecid and oseltamivir on Influenza virus replication

J Murray, DE Martin, FD Sancilio, RA Tripp - Viruses, 2023 - mdpi.com
Influenza can cause respiratory infections, leading to significant morbidity and mortality in
humans. While current influenza vaccines offer varying levels of protection, there remains a …

Genetics in light of transcriptional adaptation

Z Kontarakis, DYR Stainier - Trends in Genetics, 2020 - cell.com
Genetics has recently benefited from the genome engineering revolution: genes can be
knocked out, knocked down, or activated more easily than ever before. This range of genetic …

Repositioning drugs and biologics: Retargeting old/existing drugs for potential new therapeutic applications.

BS Sekhon - Journal of Pharmaceutical Education & …, 2013 - search.ebscohost.com
Drug discovery and development is a time consuming, costly and risky venture. As an
alternative approach, pharmaceutical companies have adopted drug repositioning (also …

[HTML][HTML] Probenecid Inhibits Human Metapneumovirus (HMPV) Replication In Vitro and in BALB/c Mice

HC Bergeron, J Crabtree, T Nagy, DE Martin, RA Tripp - Viruses, 2024 - mdpi.com
Human metapneumovirus (HMPV) is an important cause of acute respiratory tract infection
and causes significant morbidity and mortality. There is no specific antiviral drug to treat …